Altamira Therapeutics Ltd. announced that the Company's US subsidiary has received 510(k) clearance from the FDA to market its nasal spray Bentrio ("Bentrio Allergy Blocker") for the treatment of allergic rhinitis (hay fever).
Background: The aim of this work was to describe clinical similarities and differences between allergic and nonallergic asthmatics, notably concerning the nasosinusal involvement.
This document updates UK Haemophilia Centre Doctors Organization (UKHCDO) guidelines on the management of factor VIII/IX (FVIII/IX) inhibitors in congenital haemophilia (Hay et al, 2000, 2006).
Sunovion Pharmaceuticals Inc. announced the nationwide US availability of Zetonna (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of...
Relief of symptoms caused by allergic conditions such as hay fever, allergic rhinitis, perennial rhinitis, urticaria etc., which are responsive to antihistamine.
Containing relevant Learning Zones, guidelines, trials and news.
For the symptomatic relief of catarrh, hay fever and nasal congestion.
Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals.